RDLTR

Short for Read Later. Save links from any browser or phone. Click to save, read to clear. The full tour

One line. Many voicesSeek and you shall find

www.nytimes.com faviconEli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value - The New York Times

kept by

Eli Lilly, the drugmaker behind Zepbound and Mounjaro, became the first health-care company to achieve a $1 trillion market value.